BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu J, Fang T, Yun C, Liu X, Cai X. Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers. Front Mol Biosci 2022;9:847835. [DOI: 10.3389/fmolb.2022.847835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu C, Mohan SC, Wei J, Seki E, Liu M, Basho R, Giuliano AE, Zhao Y, Cui X. Breast cancer liver metastasis: Pathogenesis and clinical implications. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1043771] [Reference Citation Analysis]
2 Gámez-Chiachio M, Sarrió D, Moreno-Bueno G. Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs. Cancers (Basel) 2022;14:4543. [PMID: 36139701 DOI: 10.3390/cancers14184543] [Reference Citation Analysis]
3 Huang L, Shi Y. Editorial: The use of chemotherapy in treating gastric cancers. Front Oncol 2022;12:974023. [DOI: 10.3389/fonc.2022.974023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Demir Cetinkaya B, Biray Avci C. Molecular perspective on targeted therapy in breast cancer: a review of current status. Med Oncol 2022;39:149. [PMID: 35834030 DOI: 10.1007/s12032-022-01749-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pastwińska J, Karaś K, Karwaciak I, Ratajewski M. Targeting EGFR in melanoma - The sea of possibilities to overcome drug resistance. Biochim Biophys Acta Rev Cancer 2022;1877:188754. [PMID: 35772580 DOI: 10.1016/j.bbcan.2022.188754] [Cited by in F6Publishing: 2] [Reference Citation Analysis]